Medacta's Hip & Knee Reconstruction segment focuses on the design, development, and manufacturing of innovative implants and surgical instruments for total and partial joint replacement. This includes personalized solutions utilizing 3D planning tools and kinematic models to optimize implant positioning and patient outcomes. Research and development efforts are directed towards improving implant longevity, reducing post-operative pain, and enhancing range of motion. Technologies employed include advanced materials science, robotic-assisted surgery, and patient-specific instrumentation. The segment addresses osteoarthritis, rheumatoid arthritis, and traumatic injuries affecting the hip and knee joints. Medacta's GMK SpheriKA implant represents a significant advancement, achieving patient satisfaction levels comparable to hip replacements. Future opportunities include expanding the use of robotic surgery and personalized implants to improve surgical precision and patient-specific outcomes. Regulatory compliance and clinical validation are paramount, with ongoing clinical trials to demonstrate the safety and efficacy of Medacta's hip and knee reconstruction products.

Medacta's Spine Surgery segment is dedicated to providing comprehensive solutions for spinal disorders, including degenerative disc disease, spinal stenosis, and scoliosis. The segment's offerings encompass a range of spinal implants, instruments, and biologics designed to restore spinal stability, correct deformities, and alleviate pain. Research and development activities focus on minimally invasive surgical techniques, advanced biomaterials, and innovative implant designs. Technologies utilized include 3D-printed implants, robotic-assisted surgery, and intraoperative navigation systems. The segment addresses a wide spectrum of spinal pathologies, aiming to improve patient function and quality of life. Medacta collaborates with expert surgeons to develop and refine its spinal surgery solutions. Future opportunities include expanding the use of artificial intelligence and machine learning to optimize surgical planning and predict patient outcomes. Regulatory compliance and clinical evidence are essential, with ongoing clinical trials to evaluate the safety and effectiveness of Medacta's spinal surgery products.

Medacta's Sports Medicine segment focuses on developing and providing advanced solutions for the treatment of sports-related injuries and conditions. This includes arthroscopic procedures, ligament reconstruction, and cartilage repair. The segment's product portfolio encompasses a range of implants, instruments, and biologics designed to restore joint function and facilitate return to activity. Research and development efforts are directed towards minimally invasive techniques, regenerative medicine approaches, and personalized treatment strategies. Technologies employed include advanced imaging, 3D printing, and robotic-assisted surgery. The segment addresses a wide range of sports-related injuries, including ACL tears, meniscus injuries, and rotator cuff tears. Medacta's acquisition of Parcus Medical further strengthens its position in the sports medicine market. Future opportunities include expanding the use of biologics and regenerative therapies to promote tissue healing and accelerate recovery. Regulatory compliance and clinical validation are crucial, with ongoing clinical trials to evaluate the safety and efficacy of Medacta's sports medicine products.